Protective role of resveratrol against cisplatin induced ototoxicity in guinea pigs

International Journal of Pediatric Otorhinolaryngology

Volumn 76, Issue 3, 2012, Pages 404-408

  Yumusakhuylu, Ali Cemal ^a   Yazici, Mine ^b   Sari, Murat ^a   Binnetoglu, Adem ^a   Kosemihal, Ebru ^a   Akdas, Ferda ^a   Sirvanci, Serap ^a   Yuksel, Meral ^a   Uneri, Cuneyd ^a   Tutkun, Alper ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b Bakirkoy Research and Education Hospital   (Turkey)

Author keywords

Auditory brainstem response; Cisplatin; Ototoxicity; Reactive oxygen species; Resveratrol; Scanning electron microscopy

Indexed keywords

ALCOHOL; CISPLATIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDITORY THRESHOLD SHIFT; BRAIN STEM RESPONSE; COCHLEA; CONTROLLED STUDY; DEEP SEDATION; DRUG EFFICACY; EAR PROTECTION; FOLLOW UP; GUINEA PIG; HAIR CELL; HISTOLOGY; MALE; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; RANDOMIZATION; SCANNING ELECTRON MICROSCOPY; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CISPLATIN; COCHLEA; DISEASE MODELS, ANIMAL; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; GUINEA PIGS; HEARING LOSS, SENSORINEURAL; MALE; REACTIVE OXYGEN SPECIES; STILBENES;

EID: 84856806355     PISSN: 01655876     EISSN: 18728464     Source Type: Journal    
DOI: 10.1016/j.ijporl.2011.12.021     Document Type: Article

References (36)

1. Hartmann J.T., Lipp H.-P. Toxicity of platinum compounds. Expert Opin. Pharmacother. 2003, 4:889-901.
2. Rybak L.P., Mukherjea D., Jajoo S., Ramkumar V. Cisplatin ototoxicity and protection: clinical and experimental studies. Tohoku J. Exp. Med. 2009, 219:177-186.
3. Li Y., Womer R.B., Silber J.H. Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose. Eur. J. Cancer 2004, 40:2445-2451.
4. Laurell G., Bagger-Sjoback D. Dose-dependent inner ear changes after i.v administration of cisplatin. J. Otolaryngol. 1991, 20:158-167.
5. Choe W.T., Chinosornvatana N., Chang K.W. Prevention of cisplatin ototoxicity using transtympanic N-acetylcysteine and lactate. Otol. Neurotol. 2004, 25:910-915.
6. Wimmer C., Mees K., Stumpf P., Welsch U., Reichel O., Suckfull M. Round window application of d-methionine, sodium thiosulfate, brain-derived neurotrophic factor and fibroblast growth factor-2 in cisplatin-induced ototoxicity. Otol. Neurotol. 2004, 25:33-40.
7. Church M.W., Blakley B.W., Burgio D.L., Gupta A.K. WR-2721(amifostine) ameliorates cisplatin-induced hearing loss but causes neurotoxicity in hamsters. J. Assoc. Res. Otolaryngol. 2004, 5:227-237.
8. Korver K., Rybak L.P., Whitworth C., Campbell K.C.M. Round window application of d-methionine provides complete cisplatin otoprotection. Otolaryngol. Head Neck Surg. 2002, 126:683-689.
9. Kalkanis J.G., Whitworth C., Rybak L.P. Vitamin E reduces cisplatin ototoxicity. Laryngoscope 2004, 114:538-541.
10. Daldal A., Odabasi O., Serbetcioglu B. The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigs. Otolaryngol. Head Neck Surg. 2007, 137(5):747-752.
11. Hyppolito M.A., de Oliveira J.A., Rossato M. Cisplatin ototoxicity and otoprotection with sodium salicylate. Eur. Arch. Otorhinolaryngol. 2006, 263(9):798-803.
12. Chen X., Frisina R.D., Bowers W.J., Frisina D.R., Federoff H.J. HSV ampliconmediated neurotrophin-3 expression protects murine spiral ganglion neurons from cisplatin induced damage. Mol. Ther. 2001, 3:958-963.
13. So H.S., Park C., Kim H.J., Lee J.H., Park S.Y., Lee J.H., Lee Z.W., Kim H.M., Kalinec F., Lim D.J., Park R. Protective effect of T-type calcium channel blocker flunarizine on cisplatin-induced death of auditory cells. Hear Res. 2005, 204(1-2):127-139.
14. Lynch E.D., Gu R., Pierce C., Kil J. Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen. Hear Res. 2005, 201(1-2):81-89.
15. Fremont L. Minireview biological effets of resveratrol. Life Sci. 2000, 66(8):663-673.
16. Asensi M., Medina I., Ortega A., Carretero J., Baño M.C., Obrador E., Estrela J.M. Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic. Biol. Med. 2002, 33(3):387-398.
17. Seidman M., Babu S., Tang W., Naem E., Quirk W.S. Effects of resveratrol on acoustic trauma. Otolaryngol. Head Neck Surg. 2003, 129(5):463-470.
18. Soleas G.J., Diamands E.P., Goldberd D.M. Resveratrol: a molecule whose time has come and gone?. Can. Soc. Clin. Chem. 1997, 30(2):91-113.
19. Çetin R., Devrim E., Kiliçoglu B., Avci A., çandir ö., Durak I. Cisplatin impairs antioxidant system and causes oxidation in rat kidney tissues: possible protective roles of natural antioxidant foods. J. Appl. Toxicol. 2006, 26:42-46.
20. Ozgova S., Harmanet J., Gut I. Different antioxidant effects of polyphenols on lipid peroxidation and hydroxyl radicals in the NADPH-, Fe-ascorbate- and Fe-microsomal systems. Biochem. Pharmacol. 2003, 66:1127-1137.
21. Yilmaz ö., Keser S., Tuzcu M., çetintaş B. Resveratrol (trans-3,4',5 trihydroxystilbene) decreases lipid peroxidation level and protects antioxidant capacity in sera and erythrocytes of old female Wistar rats induced by the kidney carcinogen potassium bromate. Environ. Toxicol. Pharmacol. 2007, 24:79-85.
22. Gedik E., Girgin S., Ozturk H., Obay B.D., Ozturk H., Buyukbayram H. Resveratrol attenuates oxidative stress and histological alterations induced by liver ischemia/reperfusion in rats. World J. Gastroenterol. 2008, 14(46):7101-7106.
23. Penumathsa S.V., Maulik N. Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease. Can. J. Physiol. Pharmacol. 2009, 87(4):275-286.
24. Olas B., Washowicz B. Resveratrol, a phenolic antioxidant with effects on blood platelet functions. Platelets 2005, 16:251-260.
25. Dey A., Guha P., Chattopadhyay S., Bandyopadhyay S.K. Biphasic activity of resveratrol on indomethacin-induced gastric ulcers. Biochem. Biophys. Res. Commun. 2009, 27 & 381(1):90-95.
26. Zhang Q., Tang X., Lu Q.Y., Zhang Z.F., Brown J., Le A.D. Resveratrol inhibits hypoxiainduced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. Mol. Cancer Ther. 2005, 4(10):1465-1474.
27. Do Amaral C.L., Francescato H.D., Coimbra T.M., Costa R.S., Darin J.D., Antunes L.M., Bianchi Mde L. Resveratrol attenuates cisplatin-induced nephrotoxicity in rats. Arch. Toxicol. 2008, 82(6):363-370.
28. Bonabi S., Caelers A., Monge A., Huber A., Bodmer D. Resveratrol protects auditory hair cells from gentamicin toxicity. Ear Nose Throat J. 2008, 87(10):570-573.
29. Sehitoglu M.A., Uneri C., Celikoyar M.M., Uneri A. Surgical anatomy of the guinea pig middle ear. Ear Nose Throat J. 1990, 69:91-97.
30. López-González M.A., Lucas M., Delgado F., Diaz P. The production of free oxygen radicals and nitric oxide in the rat cochlea. Neurochem. Int. 1998, 33(1):55-59.
31. Uneri C., Sari M., Baĝlam T., Polat S., Yüksel M. Effects of vitamin E on cigarette smoke induced oxidative damage in larynx and lung. Laryngoscope 2006, 116(1):97-100.
32. Madnani D., Li G., Frenz C.M., Frenz D.A. Oral ethanol potentiates the loss of outer hair cells in cisplatin-exposed rats. Otolaryngol. Head Neck Surg. 2007, 137:327-331.
33. Fetoni A.R., Quaranta N., Marchese R., Cadoni G., Paludetti G., Sergi B. The protective role of tiopronin in cisplatin ototoxicity in Wistar rats. Int. J. Audiol. 2004, 43(8):465-470.
34. Rybak L.P. Mechanisms of cisplatin ototoxicity and progress in otoprotection. Curr. Opin. Otolaryngol. Head Neck Surg. 2007, 15(5):364-369.
35. De Vita V.T. Principles of cancer management: chemotherapy. Cancer: Principles and Practice of Oncology 1997, 333-347. Lippincott-Raven, Philadelphia. 5th ed. De Vita Vt, S. Hellman, S.A. Rosenberg (Eds.).
36. Rybak L.P., Whitworth C.A., Mukherjea D., Ramkumar V. Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res. 2007, 226(1-2):157-167.